Hugh J. Herdon

1.6k citations

39 papers · 1.2k indexed · h-index 20

Cellular and Molecular Neuroscience top 2%
Molecular Biology top 10%
Cognitive Neuroscience top 10%
Endocrine and Autonomic Systems top 5%
Psychiatry and Mental health top 10%

Co-authors: Stefan R. Nahorski Christopher J. Langmead J Strupish Martyn Wood Arthur Christopoulos Michael Wilkinson Jeffrey C. Jerman Rod A. Porter
Topics: Neuroscience and Neuropharmacology Research (22 papers)Receptor Mechanisms and Signaling (13 papers)Amino Acid Enzymes and Metabolism (8 papers)
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Biological Psychiatry
Journals: NeuroImage Brain Research FEBS Letters
Partner nations: United Kingdom United States Australia

In The Last Decade

Hugh J. Herdon

38 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hugh J. Herdon

Since Specialization

Citations

This map shows the geographic impact of Hugh J. Herdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh J. Herdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh J. Herdon more than expected).

Fields of papers citing papers by Hugh J. Herdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh J. Herdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh J. Herdon. The network helps show where Hugh J. Herdon may publish in the future.

Co-authorship network of co-authors of Hugh J. Herdon

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh J. Herdon. A scholar is included among the top collaborators of Hugh J. Herdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh J. Herdon. Hugh J. Herdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship Between Glycine Transporter 1 Inhibition as Measured with Positron Emission Tomography and Changes in Cognitive Performances in Nonhuman Primates 2014 ·Neuropsychopharmacology ·Stacy A. Castner,N Venkateswaramurthy,Khanum Ridler,Hugh J. Herdon,Brooke M. Roberts,David Weinzimmer,Yiyun Huang,M. Zheng,Eugenii A. Rabiner,Roger N. Gunn,Richard E. Carson,Graham V. Williams,Marc Laruelle	23
2	Acylglycinamides as inhibitors of glycine transporter type 1 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Roderick A. Porter,Amanda Johns,D. Nash,(unknown),Paul Wyman,Hugh J. Herdon,Simon J. Teague,(unknown),Stefano Fontana,Laurie Gordon	1
3	Identification and evaluation of [¹¹C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography 2010 ·Synapse ·Jan Passchier,Gabriella Gentile,Rod A. Porter,Hugh J. Herdon,Cristian Salinas,Steen Jakobsen,(unknown),Marc Laruelle,Roger N. Gunn	27
4	Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat 2008 ·Psychopharmacology ·Alessandro Gozzi,Hugh J. Herdon,Adam J. Schwarz,Simone Bertani,Valerio Crestan,(unknown),Angelo Bifone	50
5	Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors 2007 ·Molecular Pharmacology ·Lauren T. May,Vimesh A. Avlani,Christopher J. Langmead,Hugh J. Herdon,Martyn Wood,Patrick M. Sexton,Arthur Christopoulos	98
6	1,3-Diaminopropan-2-ol Sulfonamides as potent and selective inhibitors of the glycine transporter type 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Shahzad S. Rahman,Steven Coulton,Hugh J. Herdon,Graham F. Joiner,Jian Jin,Roderick A. Porter	7
7	Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist 2005 ·Molecular Pharmacology ·Christopher J. Langmead,(unknown),Ian T. Forbes,Clive L. Branch,Arthur Christopoulos,Martyn Wood,Hugh J. Herdon	90
8	Characterisation of the binding of [³H]‐SB‐674042, a novel nonpeptide antagonist, to the human orexin‐1 receptor 2004 ·British Journal of Pharmacology ·Christopher J. Langmead,Jeffrey C. Jerman,Stephen Brough,Claire M. Scott,Rod A. Porter,Hugh J. Herdon	105
9	Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes 2001 ·Neuropharmacology ·Hugh J. Herdon,(unknown),Angus M. Brown,Steven Coulton,Jennifer Evans,William Cairns	78
10	Solubilisation of A Novel Anticonvulsant Binding Site From Pig Cortical Membranes 2000 ·Journal of Receptors and Signal Transduction ·C. Roberts,Brian Bond,(unknown),Hugh J. Herdon	1
11	Characterization of the binding of [¹²⁵I]‐human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor 2000 ·British Journal of Pharmacology ·Christopher J. Langmead,Philip Szekeres,(unknown),(unknown),Declan N.C. Jones,Warren D. Hirst,Gary Price,Hugh J. Herdon	50
12	Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides 2000 ·Bioorganic & Medicinal Chemistry ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Barry S. Orlek,Graham J. Riley,(unknown),Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	8
13	Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,John Evans,Michael S. Hadley,Hugh J. Herdon,Jeffrey C. Jerman,Andrew A. Parsons,Simon Read,Tania O. Stean,Mervyn Thompson,Neil Upton	46
14	Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity 1998 ·Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Jeffrey C. Jerman,Barry S. Orlek,Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	12
15	Characterization of the binding of [³H]‐SB‐204269, a radiolabelled form of the new anticonvulsant SB‐204269, to a novel binding site in rat brain membranes 1997 ·British Journal of Pharmacology ·Hugh J. Herdon,Jeffrey C. Jerman,Tania O. Stean,Derek N. Middlemiss,Wai N. Chan,Antonio Vong,John Evans,Mervyn Thompson,Neil Upton	30
16	Profile of SB‐204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures 1997 ·British Journal of Pharmacology ·Neil Upton,T.P. Blackburn,Colin A. Campbell,(unknown),Martyn L. Evans,Hugh J. Herdon,(unknown),Alison M. Ray,Tania O. Stean,Wai N. Chan,John Evans,Mervyn Thompson	39
17	The novel anticonvulsant SB 204269 binds to a stereospecific site in the mouse brain 1996 ·European Journal of Pharmacology ·Hugh J. Herdon,Jeff Jerman,Tania O. Stean,Wai N. Chan,Derek N. Middlemiss,Neil Upton	10
18	SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia 1993 ·Neuropharmacology ·Christopher D. Benham,(unknown),David G. Cooper,Michael L. Evans,Mark H Harries,Hugh J. Herdon,Jackie Meakin,(unknown),Sara Patel,Jennifer Roberts,(unknown),Stuart Smith,Nigel I. Wood,A. Jacqueline Hunter	47
19	Investigations of the roles of dihydropyridine and ?-conotoxin-sensitive calcium channels in mediating depolarisation-evoked endogenous dopamine release from striatal slices 1989 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Hugh J. Herdon,(unknown)	68
20	N-ethylmaleimide inactivates adenylate cyclase-coupled but not presynaptic striatal d-2 receptor systems 1988 ·European Journal of Pharmacology ·Hugh J. Herdon	15

About Hugh J. Herdon

Hugh J. Herdon is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience and Biochemistry, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (22 papers), Receptor Mechanisms and Signaling (13 papers) and Amino Acid Enzymes and Metabolism (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (790 citations), Endocrine and Autonomic Systems (137 citations) and Biological Psychiatry (41 citations). Hugh J. Herdon has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Stefan R. Nahorski, Christopher J. Langmead, J Strupish, Martyn Wood, Arthur Christopoulos, Michael Wilkinson, Jeffrey C. Jerman, Rod A. Porter, Vimesh A. Avlani and Patrick M. Sexton. Their work appears in journals such as NeuroImage, Brain Research and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact